Exelixis' IPO

Exelixis raised a round of funding on April 25, 2005. Investors include Public.

Exelixis, Inc. is a development-stage biotechnology company dedicated to the discovery and development of novel small molecule therapeutics for the treatment of cancer and other serious diseases. The …

Articles about Exelixis' IPO: